EU Approves Takeda’s Injectable Entyvio for IBD
EU OK Follows FDA’s Recent Rejection Of The New Formulation
Takeda has won EU approval for an injectable version of Entyvio to treat ulcerative colitis or Crohn’s disease, in contrast to the FDA’s rejection in December.